Predictive Effect of Alternative Insulin Resistance Indexes on Adverse Cardiovascular Events in Patients with Metabolic Syndrome with Heart Failure
DOI: https://doi.org/10.2147/dmso.s457598
2024-06-11
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Qian Xie, 1, &ast Chang Liu, 1, &ast Fen Liu, 2 Xuehe Zhang, 1 Zhiyang Zhang, 1 Xin An, 1 Yining Yang, 3– 6 Xiaomei Li 1 1 Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China; 2 State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China; 3 Department of Cardiology, People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, People's Republic of China; 4 Xinjiang Key Laboratory of Cardiovascular Homeostasis and Regeneration Research, Urumqi, People's Republic of China; 5 State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, People's Republic of China; 6 Key Laboratory of Cardiovascular Disease Research, First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yining Yang, Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, 91 Tianchi Road, Urumqi, 830054, People's Republic of China, Tel +86-991-4361690, Email Xiaomei Li, Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, 137 Liyushan South Road, Urumqi, 830054, People's Republic of China, Tel +86-991-4362611, Email Purpose: Metabolic Syndrome (MS) greatly increases the risk of heart disease and Heart Failure(HF). Insulin Resistance (IR) is considered to be the key to the pathophysiology of MS. The purpose of this study was to evaluate the predictive effect of different alternative indicators of IR on adverse cardiovascular events in patients with MS complicated with HF. Methods: Patients with HF who were diagnosed with MS in the heart center of the first affiliated Hospital of Xinjiang Medical University were selected continuously. The baseline data of the patients in the group were compared. The diagnostic value of alternative indexes of IR was evaluated by the working characteristic curve of subjects. The relationship between different alternative indicators of IR and survival rate was evaluated by survival curve. COX regression was used to analyze the effects of different alternative indicators of IR on the risk of end-point events. Results: The levels of TyG, TyG-BMI, TyG-WC, TG/HDL-C and METS-IR were significantly increased in patients with Major Adverse Cardiovascular Events (MACEs). Among the five alternative indexes of IR, METS-IR had the highest AUC (0.691, 95% CI:0.657– 0.752, P < 0.001) in predicting MACEs. No matter which alternative index of IR was used, the survival rate of MACEs in High group was significantly decreased. TyG, TyG-BMI, TyG-WC, TG/HDL-C and METS-IR can independently predict the occurrence of MACEs events, even if some confounding factors are adjusted. Conclusion: Our study shows that alternative indicators of IR, especially METS-IR, are independently associated with adverse cardiovascular events in patients with MS and HF. Keywords: insulin resistance indexes, metabolic syndrome, heart failure, predictive Heart failure (HF) is the end-stage manifestation of most heart diseases. HF has become the leading cause of death, hospitalization and medical expenses in people over the age of 65. 1 Traditional risk factors play an important role in HF, just as they do in many other manifestations of heart disease. It is increasingly obvious that some cardiovascular risk factors tend to gather or occur at the same time. The aggregation of some risk factors and their common responses to lifestyle changes show that they are not independent of each other, but share common root causes, mechanisms and characteristics. 2,3 It is increasingly recognized that these factors are associated with HF through various pathways. 4 Patients with metabolic syndrome (MS) are characterized by a higher risk of cardiovascular disease because there are multiple risk factors in the same individual, such as obesity, hypertension, dyslipidemia and diabetes, any of which increases the risk of cardiovascular disease. 5 According to this view, it is considered convenient to combine several risk factors into a single entity, so that patients can easily be labeled as having a higher risk of CV. 22% to 68% of HF patients showed MS phenotype. 6–8 However, compared with the general population, the existence of MS is associated with twice the risk of HF. 9, -Abstract Truncated-
endocrinology & metabolism